Abraxis Bioscience News (NASDAQ:ABBI)

Latest Abraxis Bioscience News Headlines
DateTimeSource
Headline
06/04/20078:33PMPRNUSNew Data Shows Promising Antitumor Activity with nab-paclitaxel (ABRAXANE(R)) in Combination and as a Single Agent for the Treat
Results Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting HOUSTON, June 4 /PRNewswire/ -- Leading cancer researchers affiliated with the US Oncology Research Network, one of the nation's largest cancer treatment and research networks focused on cancer treatment and research, and Abraxis BioScience... More...>>


LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
36 site:2us nasdaq abbi080517 09:09 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )